BackFulgent Genetics Overview

Fulgent Genetics Long Term Debt

Track Fulgent Genetics's long-term debt ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00

Peer average / median

Loading

Fulgent Genetics Long Term Debt History

Loading

Fulgent Genetics vs. peers: Long Term Debt Comparison

Loading

Fulgent Genetics Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Fulgent Genetics (FLGT) FAQ

Fulgent Genetics (FLGT) currently reports a long-term debt of $0 as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Fulgent Genetics's long-term debt history and peer comparisons.

Fulgent Genetics's long-term debt changed from $0 to $0 (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Fulgent Genetics reported $0 in long-term debt as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Fulgent Genetics, and consider following FLGT for alerts when major investors trade the stock.

Fulgent Genetics is classified in the Healthcare sector. On long-term debt, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FLGT with unrelated industries.